FibroGen (FGEN) Tops Q1 EPS by 8c ; Offers Guidance

FibroGen (NASDAQ: FGEN) reported Q1 EPS of ($0.33), $0.08 better than the analyst estimate of ($0.41). Revenue for the quarter came in at $55.9 million versus the consensus estimate of $36.45 million.

GUIDANCE:

FibroGen sees FY2024 revenue of $120-135 million, versus the consensus of $155.3 million.

For earnings history and earnings-related data on FibroGen (FGEN) click here.

You May Also Be Interested In

• Winnebago Industries (WGO) Misses Q3 EPS by 11c ; Offers Guidance
• SYNNEX Corp. (SNX) Tops Q2 EPS by 74c, Beats on Revenue; Offers Q3 Guidance
• BlackBerry (BB) Tops Q1 EPS by 1c, Offers Guidance